These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2808194

  • 1. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K, Shi YG, Andrews JM, Ashby JP, Wise R.
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [Abstract] [Full Text] [Related]

  • 2. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A, Hardardottir H, Bottolfsen KL.
    Chemotherapy; 1991 Sep; 37(2):98-105. PubMed ID: 2032475
    [Abstract] [Full Text] [Related]

  • 3. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
    Cooper MA, Andrews JM, Ashby JP, Matthews RS, Wise R.
    J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
    [Abstract] [Full Text] [Related]

  • 5. Activity of temafloxacin against respiratory pathogens.
    Swanson RN, Hardy DJ, Chu DT, Shipkowitz NL, Clement JJ.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR.
    Am J Med; 1991 Dec 30; 91(6A):31S-34S. PubMed ID: 1662893
    [Abstract] [Full Text] [Related]

  • 7. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Nov 30; 28(5):719-25. PubMed ID: 1663930
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL, Jones RN.
    J Antimicrob Chemother; 1989 Apr 30; 23(4):527-35. PubMed ID: 2745259
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ.
    Am J Med; 1991 Dec 30; 91(6A):19S-23S. PubMed ID: 1662890
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
    Rolston KV, Ho DH, LeBlanc B, Gooch G, Bodey GP.
    Eur J Clin Microbiol Infect Dis; 1988 Oct 30; 7(5):684-6. PubMed ID: 3143585
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N, Inoue M, Inoue K, Yamaguchi T, Mitsuhashi S.
    Chemotherapy; 1990 Oct 30; 36(5):345-55. PubMed ID: 2209168
    [Abstract] [Full Text] [Related]

  • 12. In-vitro activity of temafloxacin for gram-positive pathogens.
    Bille J, Glauser MP.
    J Antimicrob Chemother; 1991 Dec 30; 28 Suppl C():9-14. PubMed ID: 1664835
    [Abstract] [Full Text] [Related]

  • 13. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A, Chuard C, Vaudaux PE, Schrenzel J, Lew DP.
    Antimicrob Agents Chemother; 1995 Aug 30; 39(8):1655-60. PubMed ID: 7486895
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.
    Segreti J, Kessler HA, Kapell KS, Trenholme GM.
    Antimicrob Agents Chemother; 1989 Jan 30; 33(1):118-9. PubMed ID: 2712543
    [Abstract] [Full Text] [Related]

  • 15. The in-vitro activity of temafloxacin, against gram-positive bacteria.
    Mandell LA, Lawrence T, Rotstein C, Gorzynski EA, Beam TR, Amsterdam D.
    J Antimicrob Chemother; 1991 Dec 30; 28 Suppl C():15-24. PubMed ID: 1664826
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Drugs Exp Clin Res; 1992 Dec 30; 18(8):311-7. PubMed ID: 1338041
    [Abstract] [Full Text] [Related]

  • 17. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F, Naber KG, Kinzig M, Mahr G, Muth P.
    Am J Med; 1991 Dec 30; 91(6A):51S-66S. PubMed ID: 1662896
    [Abstract] [Full Text] [Related]

  • 18. In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1992 Jun 30; 29(6):639-47. PubMed ID: 1506348
    [Abstract] [Full Text] [Related]

  • 19. Temafloxacin: an overview.
    Pankey GA.
    Am J Med; 1991 Dec 30; 91(6A):166S-172S. PubMed ID: 1662889
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R.
    J Antimicrob Chemother; 2004 May 30; 53(5):783-92. PubMed ID: 15056651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.